The PNET Cancer Foundation is proud to announce that it is a funding partner in the AIM Project – a major Australian project conducting research into all children’s brain cancers. The project is being led by the Robert Connor Dawes Foundation (RCD), in conjunction with ANZCHOG (Australia and New Zealand Children’s Haematology and Oncology Group).…
Histologically defined central nervous system primitive neuro‐ectodermal tumours (CNS‐PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types (published in 2013)
Research published in 2012 into CNS PNET molecular sub groups with distinctive features
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours:
an integrative genomic analysis (Published in 2012)
‘Researchers from the University of Texas MD Anderson Cancer Center in Houston have discovered that an enzyme helps brain tumors to grow. This finding offers the potential for new tumor treatment approaches.’
This article discusses a recent study by the University of Edinburgh’s school of biological sciences that found potential for the main ingredient found in olive oil, oleic acid to stimulate the production of a molecule that can prevent the growth of cancer causing proteins.
A new drug has been approved by the US FDA that targets cancer by genetic marker. Clinical trials have shown that the drug has helped shrink tumours in some patients and it is believed that the drug can assist the body’s immune system to fight the cancer. The drug is not body part specific and…